The emerging field of peptidic therapeutics represents a exciting paradigm shift in how we manage disease and maximize physical performance. Differing from traditional small molecules, short-chain proteins offer remarkable specificity, often focusing on specific receptors or enzymes with unprecedented accuracy. This focused action lessens off-targe